T3 Pharmaceuticals AG’s CHF19.3 Million Series C Financing Round

Paolo Bossi

VISCHER advises T3 Pharmaceuticals AG on all legal issues related to the transaction. T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech advancing immuno-oncology with its bacteria-based…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now